ALFREDO
RODRÍGUEZ ANTOLÍN
Profesor asociado de Ciencias de la Salud
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublications in collaboration with researchers from Hospital Universitario de Canarias (7)
2022
-
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 4
-
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 13
2021
-
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
Scientific Reports, Vol. 11, Núm. 1
2020
-
Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate/severe luts-bph: A subset analysis of the qualiprost study
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14
2018
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
BJU International, Vol. 122, Núm. 6, pp. 1049-1065
2017
-
Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study – GESCAP group
Actas Urologicas Espanolas, Vol. 41, Núm. 6, pp. 359-367
2016
-
Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP
Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216